Document Detail


Warranty periods for normal myocardial perfusion stress SPECT.
MedLine Citation:
PMID:  25116906     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: To assess different warranty periods following a normal myocardial perfusion SPECT based on patients' clinical characteristics and the type of stress performed.
METHODS AND RESULTS: A study was done of 2,922 consecutive patients (62.9 ± 13 years; 53.4% women) with a normal stress-rest SPECT. The warranty period was defined as the period during which patients remained at a low risk (<1% events/year) of total mortality (TM), or hard events (HE) (cardiac death or non-fatal myocardial infarction). Of these patients, 2,051 were given an exercise myocardial perfusion imaging (Ex-MPI); 461 submaximal exercise plus dipyridamole (Ex+Dipy-MPI); and 410 dipyridamole (Dipy-MPI). During a mean follow-up of 5 ± 3.3 years, a significant reduction (P < .05) of the warranty period for TM (13.5, 9.6 and 8 months) and HE (34.8, 20.5 and 8.2 months) was observed, for Ex-MPI, Ex+Dipy-MPI and Dipy-MPI, respectively. Other warranty period determinants were the clinical variables of age, sex, diabetes and known coronary artery disease. An abnormal left ventricular ejection fraction on gated-SPECT also significantly shortened the warranty period for HE in patients undergoing Ex+Dipy-MPI (P = .001) or Dipy-MPI alone (P = .007).
CONCLUSIONS: The warranty period for a normal stress-rest SPECT is highly variable since it is primarily determined by the type of stress, the patient's clinical characteristics and LVEF.
Authors:
Guillermo Romero-Farina; Jaume Candell-Riera; Santiago Aguadé-Bruix; Ignacio Ferreira-González; Gemma Cuberas-Borrós; Nazarena Pizzi; David García-Dorado
Related Documents :
24077606 - Time-perspective in cardiovascular risk of nsaid use after first-time myocardial infarc...
18647916 - Dual-source ct for visualization of the coronary arteries in heart transplant patients ...
25002016 - Differences in short-term versus long-term outcomes of older black versus white patient...
23164476 - Clinical presentation and predictors of target vessel revascularization after drug-elut...
24685816 - Impact of multivessel disease on infarct size among stemi patients undergoing primary a...
6768876 - Use of mannitol to obviate propranolol-induced myocardial depression in ischemic canine...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-13
Journal Detail:
Title:  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology     Volume:  -     ISSN:  1532-6551     ISO Abbreviation:  J Nucl Cardiol     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423534     Medline TA:  J Nucl Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An energy-efficient and compact clustering scheme with temporary support nodes for cognitive radio s...
Next Document:  What's Different About Patients With Hematologic Malignancies? A Retrospective Cohort Study of Cance...